BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31605225)

  • 1. Circulating Tumor Cells: High-Throughput Imaging of CTCs and Bioinformatic Analysis.
    Keomanee-Dizon K; Shishido SN; Kuhn P
    Recent Results Cancer Res; 2020; 215():89-104. PubMed ID: 31605225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer.
    Orrapin S; Thongkumkoon P; Udomruk S; Moonmuang S; Sutthitthasakul S; Yongpitakwattana P; Pruksakorn D; Chaiyawat P
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
    Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
    J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in the clinical cancer diagnosis.
    Zhang P; Zhou H; Lu K; Wang Y; Feng T
    Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscale Laminar Vortices for High-Purity Extraction and Release of Circulating Tumor Cells.
    Hur SC; Che J; Di Carlo D
    Methods Mol Biol; 2017; 1634():65-79. PubMed ID: 28819841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Phenotypic Profiling of CTCs in Whole Blood Using an Integrated Microfluidic Device.
    Pei H; Li L; Wang Y; Sheng R; Wang Y; Xie S; Shui L; Si H; Tang B
    Anal Chem; 2019 Sep; 91(17):11078-11084. PubMed ID: 31373191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells: Fluid Surrogates of Solid Tumors.
    Thiele JA; Bethel K; Králíčková M; Kuhn P
    Annu Rev Pathol; 2017 Jan; 12():419-447. PubMed ID: 28135562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Analysis of Circulating Tumor Cells.
    Thiele JA; Pitule P; Hicks J; Kuhn P
    Methods Mol Biol; 2019; 1908():243-264. PubMed ID: 30649733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
    De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
    Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using CTCs for pharmacogenomic analysis.
    Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
    Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
    Chen S; El-Heliebi A; Kroneis T
    Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
    Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
    J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.